Marvel’s Isaac Perlmutter Donates $9 Million to Fund Cancer Research at NYU Langone, Technion

Marvel Entertainment CEO Isaac Perlmutter and his wife Laura have donated $9 million as part of a grant to fund cancer research at NYU Langone Medical Center and the Technion-Israel Institute of Technology.

The first $3 million will finance six cancer-focused research projects that will be conducted by teams spearheaded by co-investigators from both NYU Langone and the Technion. The joint venture between the two institutions was formed as a way to attract additional world-class support from institutions and individuals who are dedicated to eradicating cancer through focused and efficient research.

The remaining $6 million of the Perlmutters’ grant will be used to establish a state-of-the-art research facility at the Technion’s campus in Israel and have a principal focus on the emerging field of cancer metabolomics.

“Bringing together the unique expertise of researchers from both NYU and the Technion will hopefully enable us to overcome some of the most difficult challenges in treating cancer patients,” said Technion distinguished professor Aaron Ciechanover, the 2004 Nobel Prize Laureate in chemistry, and distinguished research professor and head of the David and Janet Polak Cancer and Vascular Biology Research Center at the Technion Faculty of Medicine.

The Perlmutters have long championed cancer research. In January 2014, the two donated more than $50 million to advance cancer research and treatment at NYU Langone. NYU Langone renamed the NYU Cancer Institute the Laura and Isaac Perlmutter Cancer Center as part of the gift. The two also both serve as members of the board of trustees at NYU Langone.

The Perlmutters also have backed Israeli institutions like the Technion to spearhead many of the world’s advances in medicine, science and technology.

“Ike and I have long sought for ways to link the state-of-the-art scientific and research advances being made in Israel with our deep commitment to NYU Langone Medical Center,” Laura Perlmutter said. “The partnership between the Technion and NYU Langone allows us to launch a focused cancer research and treatment approach. We are confident that this collaborative effort, which avoids duplication of research initiatives and creates efficiencies among marquee donors and researchers, will lead to dramatic results in the fight against this terrible disease.”

The Perlmutter grant coincides with the appointments of cancer biologist Benjamin Neel, an expert in the field of cell signal transduction, who joined the NYU Langone faculty as director of the Perlmutter Cancer Center. Eyal Gottlieb, a world leader in cancer metabolism, also has been recruited to lead the new research facility at the Technion. Dr. Neel will work closely with Prof. Ciechanover to lead the collaborative cancer research effort between the two institutions.

In addition, Neel will oversee at NYU Langone the building of translational programs in immunotherapy, cancer genetics-targeted therapies and epigenetics and imaging, as well as expanded programs in clinical care, community outreach and supportive oncology. He previously served as director of the Ontario Cancer Institute at Princess Margaret Cancer Center, a position he held since 2007.

Gottlieb currently serves as director of the Cancer Metabolism Research Unit at the Cancer Research U.K., Beatson Institute in Glasgow, Scotland. His work principally focuses on cancer metabolism and metabolomics, combining analytical chemistry with basic cancer research to explore metabolic adaptations and vulnerabilities of cancer and with it, new potential clinical approaches for cancer treatment.

“NYU Langone and the Technion have a shared, longstanding commitment to advancing cancer research,” said Dafna Bar-Sagi, senior VP and vice dean for science at NYU Langone, chief science officer at NYU School of Medicine, and a principal architect of the NYU Langone-Technion partnership. “We are now at a great moment in our institutions’ illustrious histories, a point from which we can jointly leverage the talent and creativity of our researchers toward accelerating breakthroughs. The foresight and the generosity of the Perlmutters, particularly at this time of financial challenge in funding for basic research, will have tremendous impact.”

More Biz

  • Help Wanted: Amazon Studios International Execs

    Help Wanted: Amazon Studios International Execs Talk European Expansion

    If there’s a perfect example of Amazon Studios’ strategy with its local-language international TV content, Japan’s “Documental” would be it. The series revolves around 10 comedians who battle to make one another laugh in an elimination-style competition. James Farrell, Amazon Studios’ head of international originals, said it was a good example of an unconventional idea [...]


    Netflix and Ava DuVernay Sued by Police Interrogation Firm

    The company behind a controversial police interrogation technique filed a federal lawsuit on Monday against Netflix and director Ava DuVernay, claiming that it was defamed in DuVernay’s miniseries on the Central Park jogger case. John E. Reid and Associates developed the Reid Technique in the late 1940s, and it has continued to offer training materials [...]

  • Arnold Schwarzenegger'Terminator: Dark Fate' film panel,

    Arnold Schwarzenegger Trades CAA for UTA

    Arnold Schwarzenegger has departed his former agency CAA and signed with UTA, which will represent the global superstar and two-time Governor of California in all areas. Schwarzenegger, whose films have grossed more than $4.7 billion worldwide, is set to reprise his celebrated role in the “Terminator” franchise, starring in “Terminator: Dark Fate.” He will also [...]

  • Patrick Moran

    Former ABC Studios Head Patrick Moran Signs Amazon Overall Deal

    Patrick Moran has signed an overall deal with Amazon, Variety has learned. The news comes around three months after it was announced that Moran would be exiting his role as president of ABC Studios following restructuring in the wake of the Disney-21st Century Fox merger. Under his new deal, Moran will work with Amazon Studios to [...]

  • Pamela Adlon

    Pamela Adlon Signs With CAA (EXCLUSIVE)

    Multi-hyphenate Pamela Adlon has signed with CAA for representation, Variety has learned exclusively. Due to the ongoing dispute between the Writers Guild and the talent agencies, however, CAA will not be representing Adlon for writing. In addition to writing, Adlon is an actress, producer, and director. She continues to be repped by Cunningham Escott Slevin Doherty [...]

  • Obit Obituary Placeholder

    Talent Agent Joseph Eric Rice Dies at 61

    Joseph Eric Rice, a talent agent who headed JR Talent Group, died unexpectedly at his home in Laguna Beach, Calif. He was 61. Rice headed his own talent agency based in Studio City where he primary handled actors. Earlier in his career, he headed the theatrical department at Abrams Artists Agency. Rice was born in [...]

  • Terry Back chairman ACF

    Veteran U.K. Media Investor Terry Back Joins ACF as Chairman

    CANNES — Veteran U.K. film industry investor Terry Back has joined ACF investment bank as chairman. ACF, headed by CEO Thomas Dey, has been at the forefront of the M&A activity around independent TV and film production outfits, mostly in the unscripted TV arena. ACF is in the midst of expanding its activities in the [...]

More From Our Brands

Access exclusive content